Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Edwards Lifesciences Corp (NYSE:EW)

100.02
Delayed Data
As of May 23
 +0.91 / +0.92%
Today’s Change
62.53
Today|||52-Week Range
112.00
+26.64%
Year-to-Date
Edwards Lifesciences (EW) Stock Price Target Raised at Canaccord
May 23 / TheStreet.com - Paid Partner Content
Thermo Fisher Posts Solid Q1; Affimetrix Integration Continues
May 18 / Zacks.com - Paid Partner Content
S&P 500 to Celebrate One Year of New High: Top ETFs & Stocks
May 20 / Zacks.com - Paid Partner Content
Luminex (LMNX) to Buy Nanosphere, Eyes Portfolio Expansion
May 17 / Zacks.com - Paid Partner Content
Baxter (BAX) Raised to Strong Buy on Estimate Revisions
May 20 / Zacks.com - Paid Partner Content
Accelerate Diagnostics (AXDX) Jumps: Stock Rises 6.1%
May 16 / Zacks.com - Paid Partner Content
Quality Systems (QSII) Q4 Earnings Disappoint, Stock Falls
May 20 / Zacks.com - Paid Partner Content
Can Edwards Lifesciences (EW) Stock Continue to Grow Earnings?
May 16 / Zacks.com - Paid Partner Content
Masimo (MASI) Scales a 52-Week High on Strong Q1 Results
May 19 / Zacks.com - Paid Partner Content
Fresenius Medical (FMS) Q1 Earnings & Sales Lag Estimates
May 11 / Zacks.com - Paid Partner Content
'Mad Money' Lightning Round: Edwards Lifesciences Is Going Higher
May 19 / TheStreet.com - Paid Partner Content
Penumbra (PEN) Q1 Earnings & Revenues Beat Expectations
May 10 / Zacks.com - Paid Partner Content
Strong Q4 for PetMed (PETS), New Order & Reorder Sales Gain
May 19 / Zacks.com - Paid Partner Content
Inogen (INGN) Q1 Earnings Miss Estimates, FY16 View Intact
May 10 / Zacks.com - Paid Partner Content
Edwards Lifesciences Presents Positive Data on Sapien3
May 18 / Zacks.com - Paid Partner Content